prescription pills

Kmart Corporation to Pay U.S. $32.3 Million to Resolve False Claims Act Allegations for Overbilling Federal Health Programs for Generic Prescription Drugs

Kmart Corporation, a wholly owned subsidiary of Sears Holdings Corporation (SHC), has agreed to pay $32.3 million to the United States to settle allegations that in-store pharmacies in Kmart stores failed to report discounted prescription drug prices to Medicare Part D, Medicaid, and TRICARE. The False Claims Act lawsuit, which was filed in 2008 by...
Continue reading…
bank skyscraper

Iberiabank pays over $11.6 million to settle whistleblower DOJ suit for false claims for loan guarantees

The Justice Department announced that IBERIABANK Corporation, IBERIABANK and IBERIABANK Mortgage Company (collectively, IBERIABANK) have agreed to pay the United States $11,692,149 to resolve allegations that they violated the False Claims Act by falsely certifying they were complying with Federal requirements in order to obtain insurance on mortgage loans from the...
Continue reading…

Mylan Pharma pays Massachusetts $20.3 million for underpaid rebates to Medicaid for EpiPens

Pharmaceutical company Mylan will pay a total of $20.3 million to the Massachusetts Medicaid program (MassHealth) to resolve allegations that it knowingly underpaid rebates owed to the Medicaid program for EpiPens dispensed to MassHealth members, Attorney General Maura Healey announced today. The payment is part of a global settlement with the United States, the District...
Continue reading…

Whistleblower importers revealing custom tariff evasion by filing cases against employer or competitor under the False Claims Act

Business that are active in importing goods for sale in the United States are revealing their competitor's fraud in cheating on customs tariffs and collecting upto 30% of what the government recovers from their claims.Œ Filing a claim under the False Claims Act stops cheating competitor from fudging on tariffs and allows for a...
Continue reading…